Viewing disease through the lens of memory B cells: improving cancer and infectious disease treatment

Looking at disease through a patient’s memory B cells can reveal vulnerabilities within pathogens. In this article, Dr Purnanand Sarma, President and Chief Executive Officer of Immunome, explores how advancements in memory B-cell antibody-based treatments will improve our understanding of how these cells can aid in fighting cancer and other diseases.

A growing understanding of immunity

The art of practicing modern medicine has always been a discipline of perspective. While certain disease characteristics remain the same over time, advancements in medical research and our evolving understanding of pathological processes require a shifting lens. This concept is more true today than ever, as the world continues to face a multi-year pandemic that may ultimately lead to a new endemic virus. As an industry, we are continually forced to shift our point of view to develop novel therapeutics.